Navigation Links
NuvaRing Lawsuits Look Toward Settlement as Health Canada Issues NuvaRing Contraceptive Warning
Date:8/17/2014

Columbus, OH (PRWEB) August 17, 2014

As Merck looks to settle thousands of NuvaRing lawsuits alleging deep vein thrombosis and pulmonary embolisms in the U.S. under MDL 1964, Wright & Schulte LLC reports that Health Canada recently ordered new user restrictions for the use of the contraceptive device manufactured by Merck Canada Inc. In its safety alert, Health Canada warns that women who have migraine headaches with vision problems or constant stomach pain due to problems in the pancreas along with high levels of fats in the blood should not use NuvaRing. There are currently 3,800 NuvaRing lawsuits pending in state and federal courts in the U.S. All of the NuvaRing complaints contend women suffered serious side-effects, including deep being thrombosis (blood clots in the legs), pulmonary embolism (blood clots in the lungs), strokes, heart attacks and death as a result of using the monthly contraceptive device. (In re: NuvaRing Products Liability Litigation, MDL 1964, JPML, U.S. District Court, Eastern District of Missouri)
[healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014
/40841a-eng.php, July 31, 2014]

Health Canada stated in its NuvaRing safety alert that the vaginal contraceptive ring should not be used by women who smoke and are over 35, or those who have more than one, or a serious form, of the following:

  • heart problems
  • high blood pressure
  • blood tests indicating abnormal levels of fats or substances that control blood clotting
  • diabetes
  • limited ability to move around for a long time after an operation

The safety alert further advised women to talk to their doctors if they begin having such side-effects as liver cancer, joint pain and swelling, uncoordinated jerking movements, skin blistering, hearing loss, gut problems and swelling around the eyes, face and lips.

NuvaRing was approved by the U.S. Food & Drug Administration (FDA) in 2001 as a once a month, flexible birth control ring. NuvaRing releases a continuous low dose of the hormones estrogen and progestin that helps prevent pregnancy. Merck has marketed the vaginal ring as being just as safe and effective as oral birth control pills. However, a FDA-funded study published in October 2011 found NuvaRing significantly increased the risk of deep vein thrombosis and pulmonary embolism in new users compared to standard low-dose birth control pills. Additionally, studies published in 2012 in The New England Journal of Medicine and the British Medical Journal indicated that NuvaRing side-effects included a higher risk of dangerous blood clots, as well as heart attacks and strokes.
[fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf, October 27, 2011]
[nejm.org/doi/full/10.1056/NEJMoa1111840; NEJM, June 2012]
[bmj.com/content/344/bmj.e2990/rr/585117, British Medical Journal, May 2012]

In February, Merck announced that it would settle all NuvaRing lawsuits in mass litigation as well as individual lawsuits in other states as long as at least 95 percent of the plaintiffs agree to accept the settlement. Merck said in a statement issued in June 6, 2014, that an “immaterial number of cases have opted out of the settlement” but the company confirmed that the “resolution will move forward as planned.” By agreeing to the settlement, Merck said that it is not admitting to any wrongdoing.
[bloomberg.com/news/2014-02-07/merck-judge-says-company-to-pay-100-million-in-nuvaring-accord.html, February 8, 2014]
[mercknewsroom.com/news/company-statements/merck-stands-behind-safety-profile-nuvaring-etonogestrelethinyl-estradiol-va, June 6, 2014]

One NuvaRing complaint filed earlier this year, within MDL 1964, alleges the plaintiff developed serious side-effects from the NuvaRing contraceptive which she began using in 2007. In December 2012, the woman began to experience breathing problems, numbness in her left arm, palpitations and other symptoms, according to the NuvaRing lawsuit. After seeking medical attention for the problems, the woman was told she had blood clots lodged within the airways of her left lung. The NuvaRing lawsuit indicated that the woman was prescribed the blood thinner Coumadin and hospitalized for two days. The complaint purports that the defendants, Organon USA, Inc. and Merck & Co., Inc., marketed NuvaRing as a safe and effective even though the companies knew about its significant risks of serious side effects.

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com
Like us on Facebook
Follow us on Twitter
Join us on Google+

Read the full story at http://www.prweb.com/releases/2014/08/prweb12096473.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugNews Update: Merck Files Challenge Over Plans For Generic NuvaRing
2. DrugRisk Legal News Adds Latest Updates on NuvaRing Contraceptives
3. New to DrugRisk: December Court Records Show Rise in NuvaRing Lawsuits
4. New Lawsuit on Alleged NuvaRing Blood Clot: Now, AttorneyOne Can Provide Advice
5. NuvaRing Lawsuit Filed by Wright & Schulte LLC After Ohio Woman Allegedly Suffered Life-Threatening NuvaRing Blood Clots, Including Bilateral Pulmonary Emboli
6. DrugNews: Latest Info Shows Rise in NuvaRing Lawsuits Alleging Blood Clots
7. NuvaRing Blood-Clotting Lawsuit Help: Resource4thePeople Reports Number of Cases in Consolidated Federal Litigation Increases
8. NuvaRing Pulmonary Embolism Lawsuit Alleges That a Colorado Woman Sustained Pulmonary Emboli Due to Use of NuvaRing Contraceptive, Reports Alonso Krangle
9. NuvaRing Lawsuit Filed by Alonso Krangle Alleges That Use of NuvaRing Caused a Louisiana Woman to Develop a Life-Threatening Blood Clot Disorder
10. NuvaRing Lawsuits Move Forward, as Federal Judge Rejects Motion for Summary Judgment in NuvaRing Lawsuit Bellwether Trial, Wright & Schulte LLC Reports
11. NuvaRing Lawsuit Filed by Alonso Krangle Alleges that a Virginia Woman Developed Pulmonary Embolism Due to NuvaRing Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
(Date:6/23/2016)... 23, 2016 The Biotechnology industry ... to present great opportunities to investors. Stock-Callers.com assesses the ... Corp. (NYSE: XON ), Vertex Pharmaceuticals Inc. ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... and receive your complimentary trade alerts at: ...
Breaking Medicine Technology: